Pharmacogenetic effect of an endothelin-1 haplotype on response to bucindolol therapy in chronic heart failure.

Find People
Find Research
Overview
Tutorials
FAQs
Edit My PROFILE
Login to PROFILES

History

Effect of vitamin E de

Loss of phospholipid a

Sodium Channels

Correlation between ol

Pharmacogenetic effect

See All (8) pages

Contact Us
If you have any questions or feedback please contact us.

Pharmacogenetic effect of an endothelin-1 haplotype on response to bucindolol therapy in chronic heart failure.

Taylor MR, Slavov D, Humphrey K, Zhao L, Cockroft J, Zhu X, Lavori P, Bristow MR, Mestroni L, Lazzeroni LC. Pharmacogenetic effect of an endothelin-1 haplotype on response to bucindolol therapy in chronic heart failure. Pharmacogenet Genomics. 2009 Jan; 19(1):35-43.

View in: PubMed

subject areas

Adrenergic beta-Antagonists
Aged
Aspartic Acid Endopeptidases
Endothelin-1
Endothelin-Converting Enzymes
Endothelins
Female
Haplotypes
Heart Failure
Humans
Linkage Disequilibrium
Male
Metalloendopeptidases
Middle Aged
Models, Genetic
Pharmacogenetics
Polymorphism, Single Nucleotide
Propanolamines
Proportional Hazards Models
Receptors, Endothelin

authors with profiles

Luisa Mestroni

Contact Us
CCTSI
About CCTSI
CCTSI Affiliated Institutions
National CTSA Consortium